Bristol-Myers Squibb Co vs eBay Inc — how do they compare? Bristol-Myers Squibb Co trades at $56.99 (market cap $116.30B), while eBay Inc trades at $112.54 (market cap $49.97B). The key difference: Bristol-Myers Squibb Co is far larger — about 2.3× eBay Inc's market cap, and Bristol-Myers Squibb Co pays the higher dividend (4.42%). Which is the better fit depends on your goals.
| BMY | EBAY | |
|---|---|---|
Market Cap | $116.30B | $49.97B |
Sector | Health | Consumer Cyclical |
52-Week High | $62.37 | $118.96 |
52-Week Low | $42.60 | $76.79 |
Enterprise Value | $152.24B | $53.31B |
Dividend Yield | 4.42% | 1.1% |
Volume | — | 5,186,418 |
Signals from Pluang's Aura AI — not financial advice
Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.
BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.
EBAY trades at $115.09, down 1.8% today, amid a bullish technical setup with strong moving average signals and key support at $114. The company shows robust profitability with a 71.79% gross margin and consistent earnings beats, while navigating a potential acquisition by GameStop. Revenue growth is steady, reaching $11.10B in 2025, though net cash flow turned negative.
Outlook remains mixed: strong fundamentals and bullish analyst sentiment (46% buy ratings) support upside, but risks include the uncertain GameStop takeover bid and competitive pressures. The stock trades above the $107.82 consensus target, suggesting limited near-term gains unless earnings surprise again.
Trailing returns across standard periods
Latest headlines on both assets
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →